Unknown

Dataset Information

0

Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors.

ABSTRACT:

SUBMITTER: Hideshima T 

PROVIDER: S-EPMC4405100 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors.

Hideshima T T   Mazitschek R R   Santo L L   Mimura N N   Gorgun G G   Richardson P G PG   Raje N N   Anderson K C KC  

Leukemia 20131022 2

Similar Datasets

Unknown The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer.
| S-EPMC4033132 | biostudies-literature
Unknown Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors.
| S-EPMC4716601 | biostudies-literature
Unknown Discovery of histone deacetylase 8 selective inhibitors.
| S-EPMC3403710 | biostudies-literature
Unknown Next-generation of selective histone deacetylase inhibitors.
| S-EPMC9065321 | biostudies-literature
Unknown Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach.
| S-EPMC5468338 | biostudies-literature
Unknown Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents.
| S-EPMC7690782 | biostudies-literature
Unknown Synthesis and Biochemical Evaluation of Biotinylated Conjugates of Largazole Analogues: Selective Class I Histone Deacetylase Inhibitors.
| S-EPMC6370329 | biostudies-literature
Unknown Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
| S-EPMC3542186 | biostudies-literature
Unknown Balancing Histone Deacetylase (HDAC) Inhibition and Drug-likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors.
| S-EPMC9303312 | biostudies-literature
Unknown Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton.
| S-EPMC3973216 | biostudies-literature